241 related articles for article (PubMed ID: 16447247)
1. Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.
Haibel H; Rudwaleit M; Brandt HC; Grozdanovic Z; Listing J; Kupper H; Braun J; Sieper J
Arthritis Rheum; 2006 Feb; 54(2):678-81. PubMed ID: 16447247
[No Abstract] [Full Text] [Related]
2. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.
Lambert RG; Salonen D; Rahman P; Inman RD; Wong RL; Einstein SG; Thomson GT; Beaulieu A; Choquette D; Maksymowych WP
Arthritis Rheum; 2007 Dec; 56(12):4005-14. PubMed ID: 18050198
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.
Brandt J; Haibel H; Cornely D; Golder W; Gonzalez J; Reddig J; Thriene W; Sieper J; Braun J
Arthritis Rheum; 2000 Jun; 43(6):1346-52. PubMed ID: 10857793
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
[TBL] [Abstract][Full Text] [Related]
5. Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis.
Maksymowych WP; Lambert RG; Brown LS; Pangan AL
J Rheumatol; 2012 Aug; 39(8):1666-74. PubMed ID: 22753648
[TBL] [Abstract][Full Text] [Related]
6. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.
Rudwaleit M
J Rheumatol; 2010 Aug; 37(8):1553-5. PubMed ID: 20675850
[No Abstract] [Full Text] [Related]
8. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.
Marzo-Ortega H; McGonagle D; Jarrett S; Haugeberg G; Hensor E; O'connor P; Tan AL; Conaghan PG; Greenstein A; Emery P
Ann Rheum Dis; 2005 Nov; 64(11):1568-75. PubMed ID: 15829577
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis.
Hu Z; Xu M; Li Q; Lin Z; Liao Z; Cao S; Wei Q; Zhang YL; Li T; Jin O; Huang J; Pan Y; Wu Y; Deng X; Gu J
Int J Rheum Dis; 2012 Aug; 15(4):358-65. PubMed ID: 22898215
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
Rudwaleit M; Baraliakos X; Listing J; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
[TBL] [Abstract][Full Text] [Related]
11. The HLA-B*2709 subtype in a woman with early ankylosing spondylitis.
Olivieri I; D'Angelo S; Scarano E; Santospirito V; Padula A
Arthritis Rheum; 2007 Aug; 56(8):2805-7. PubMed ID: 17665436
[No Abstract] [Full Text] [Related]
12. Low-dose infliximab (3 mg/kg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a randomized placebo-controlled study.
Maksymowych WP; Salonen D; Inman RD; Rahman P; Lambert RG;
J Rheumatol; 2010 Aug; 37(8):1728-34. PubMed ID: 20436073
[TBL] [Abstract][Full Text] [Related]
13. Vertebral sarcoid mimicking ankylosing spondylitis or just a co-incidence?
Malaviya AN; Sawhney S; Kapoor S; Garg S
J Assoc Physicians India; 2010 Nov; 58():709-11. PubMed ID: 21510471
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.
Braun J; Baraliakos X; Golder W; Brandt J; Rudwaleit M; Listing J; Bollow M; Sieper J; Van Der Heijde D
Arthritis Rheum; 2003 Apr; 48(4):1126-36. PubMed ID: 12687557
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial.
Huang F; Gu J; Zhu P; Bao C; Xu J; Xu H; Wu H; Wang G; Shi Q; Andhivarothai N; Anderson J; Pangan AL
Ann Rheum Dis; 2014 Mar; 73(3):587-94. PubMed ID: 23475983
[TBL] [Abstract][Full Text] [Related]
16. Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment.
Huang Y; Cheng F; Zhang X; Tang J
J Rheumatol; 2011 Sep; 38(9):2083-4. PubMed ID: 21885528
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
van der Heijde D; Kivitz A; Schiff MH; Sieper J; Dijkmans BA; Braun J; Dougados M; Reveille JD; Wong RL; Kupper H; Davis JC;
Arthritis Rheum; 2006 Jul; 54(7):2136-46. PubMed ID: 16802350
[TBL] [Abstract][Full Text] [Related]
18. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.
Machado P; Landewé RB; Braun J; Baraliakos X; Hermann KG; Hsu B; Baker D; van der Heijde D
Ann Rheum Dis; 2012 Dec; 71(12):2002-5. PubMed ID: 22915615
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis.
Braun J; Rudwaleit M; Kary S; Kron M; Wong RL; Kupper H
Rheumatology (Oxford); 2010 Aug; 49(8):1578-89. PubMed ID: 20448079
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study.
Marzo-Ortega H; McGonagle D; O'Connor P; Emery P
Arthritis Rheum; 2001 Sep; 44(9):2112-7. PubMed ID: 11592375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
